Patients play a vital role in finding better ways to treat cancer by participating in clinical trials. Thanks to patients who volunteered for studies, we now have a range of treatments that can cure or delay the progression of cancer for many years. Our patients are partners in care and partners in discovery.
As national leaders in the field, the University of Michigan Comprehensive Cancer Center's Skin Cancer Program provides care that builds on research and decades of outstanding success rates in the healing of all types of skin cancer -- melanoma, basal and squamous cell carcinomas, and Merkel cell carcinomas.
Over the past 30 years -- and through hundreds of clinical trials -- we've discovered better treatments so there's less chance of cancer coming back. With the help of clinical trials, we've also learned better methods of detecting cancer -- catching it earlier, when we have the best chance of curing it.
More than 190,000 women will be diagnosed with breast cancer this year. But only 5-10% of those breast cancers are caused by an inherited genetic mutation. The same gene can put women at a higher risk of ovarian cancer as well.
At the University of Michigan Comprehensive Cancer Center, doctors and scientists are committed to discovering new forms of treatment for head and neck cancer. By using the latest surgical techniques and incorporating the newest laboratory discoveries, we are able to preserve and rebuild the tissues of the mouth and throat so our patients can return to their daily lives with excellent function and quality of life.
Clinical research is a partnership between doctors and patients working to improve the treatment of cancer. Being in a clinical trial can mean trying new medicines to understand them better. Research can also mean comparing two types of cancer treatment to see which one is most effective. The ultimate goal of all clinical trials is to cure cancer and improve quality of life.
The collaborative spirit is at work here, allowing doctors and scientists to assist each other in advancing us toward better and more effective treatments for cancer. Be part of our progress. Be part of the Michigan Difference.
Adrenal cancer is rare. Exceptional patient care and innovative treatment strategies for adrenal cancer shouldn't be. At the University of Michigan Comprehensive Cancer Center, we apply the same multidisciplinary approach to diagnosing and treating adrenal cancer, and the same translational approach to basic and clinical research in the field, as we do for more prevalent cancer types.
U-M Cancer Center hosts online chat to answer questions about lung cancer
Make sure you have the facts about lung cancer, a disease that kills more people each year than breast, colon and prostate cancers combined. Next Thursday, (February 16 at noon), plan to join us for an on-line chat with Gregory Kalemkerian, M.D.,
director, University of Michigan Lung Cancer Clinic. Learn more and register.
UMClinicalStudies.org registers 10,000th research volunteer
Health research still faces critical shortage of volunteers nationwide.
U-M researcher receives grant to develop new approaches to treat Ewing's sarcoma
Elizabeth R. Lawlor, M.D., Ph.D. will develop new treatment approaches.
Gene linked to pancreatic cancer growth
U-M research has found the protein plays a role in development and growth of pancreatic cancer.
UMClinicalStudies.org registers 10,000th research volunteer
In recent days, the U-M Health System added its 10,000th research volunteer to our participant registry, a major milestone. There is still a great need for research participants at U-M and nationwide.
A lack of volunteers slows progress in the fight against cancer, diabetes, depression and other devastating illnesses.
Learn more.
U-M researcher receives grant to develop new approaches to treat Ewing's sarcoma
Elizabeth R. Lawlor, M.D., Ph.D. will develop new treatment approaches.
Gene linked to pancreatic cancer growth
U-M research has found the protein plays a role in development and growth of pancreatic cancer.
Avastin, Sutent increase breast cancer stem cells, U-M study shows
Cancer eventually regrows and spreads.
U-M researcher receives grant to develop new approaches to treat Ewing's sarcoma
Ewing's sarcoma is the second most common type of bone tumor in children and adolescents. Understanding how these cancer cells survive is a primary focus of
investigation in many research laboratories around the world, including
is Elizabeth Lawlor, M.D., Ph.D.
Learn more.
Gene linked to pancreatic cancer growth
U-M research has found the protein plays a role in development and growth of pancreatic cancer.
Avastin, Sutent increase breast cancer stem cells, U-M study shows
Cancer eventually regrows and spreads.
New technology allows CT scans to be done with a fraction of the conventional radiation dose
Reduces cancer risk from radiation.
Gene linked to pancreatic cancer growth, U-M study finds
A mutant protein found in nearly all pancreatic cancers plays a role not only in the cancer's development but in its continued
growth, according to a new study from U-M Comprehensive Cancer Center researchers. The finding suggests a possible target for developing
new ways to treat this deadly disease.
Learn more
Avastin, Sutent increase breast cancer stem cells, U-M study shows
Cancer eventually regrows and spreads.
New technology allows CT scans to be done with a fraction of the conventional radiation dose
Reduces cancer risk from radiation.
Winter issue of THRIVE is online
This on-line publication features research and treatment articles for our patients.
